US20120094303A1 - Device for assaying analytes in bodily fluids - Google Patents

Device for assaying analytes in bodily fluids Download PDF

Info

Publication number
US20120094303A1
US20120094303A1 US13/211,208 US201113211208A US2012094303A1 US 20120094303 A1 US20120094303 A1 US 20120094303A1 US 201113211208 A US201113211208 A US 201113211208A US 2012094303 A1 US2012094303 A1 US 2012094303A1
Authority
US
United States
Prior art keywords
container
sample
base
sampler
body fluid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/211,208
Other languages
English (en)
Inventor
Matthias W. ENGEL
Leslie Wilson
Paul Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ulti med Products International GmbH
EXPRESS DIAGNOSTICS INT'L Inc
Original Assignee
ulti med Products International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ulti med Products International GmbH filed Critical ulti med Products International GmbH
Publication of US20120094303A1 publication Critical patent/US20120094303A1/en
Priority to US13/625,608 priority Critical patent/US9462998B2/en
Priority to US14/500,230 priority patent/US9414813B2/en
Assigned to EXPRESS DIAGNOSTICS INT'L, INC. reassignment EXPRESS DIAGNOSTICS INT'L, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WILSON, LESLIE, JOHNSON, PAUL, ENGEL, MATTHIAS W.
Priority to US15/290,503 priority patent/US10076314B2/en
Priority to US16/131,742 priority patent/US20190083069A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/007—Devices for taking samples of body liquids for taking urine samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0096—Casings for storing test samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B2010/0003—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements including means for analysis by an unskilled person
    • A61B2010/0006—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements including means for analysis by an unskilled person involving a colour change
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B2010/0009—Testing for drug or alcohol abuse

Definitions

  • the present invention relates to a device for determining the presence and/or quantity of one or more analytes in a sample of human body fluid, comprising a container for receiving a sample of body fluid, and further comprising at least one test strip with an absorbent section and with reagents for determining the presence and/or quantity of one or more analytes in the sample.
  • the present invention concerns a device for collecting and testing a liquid sample, as is used in particular in tests for a drug or for multiple drugs.
  • a liquid sample as is used in particular in tests for a drug or for multiple drugs.
  • the presence and/or quantity of one or more analytes, in particular drugs of abuse is determined from a sample of a body fluid, for example saliva or urine.
  • the result can be determined visually by means of test strips.
  • test cards comprise test strips with which amphetamines and drugs such as ecstasy, cocaine, crack or opiates and cannabis are intended to be detected in parallel.
  • Suitable detection methods are, for example, immunoassays, which are highly sensitive detection methods based on the specificity of immunological reactions.
  • the substances are detected using an easily detectable and measurable indicator substance, for example radioactive isotopes, enzymes, dyes, for example gold sols, and fluorescence dyes.
  • a marked antigen or a marked antibody which is specific for the substance to be detected, is located in a first zone which first comes into contact with the liquid sample. If the sample contains an analyte that is recognized by the specific antibodies or antigens, these bind to the analyte and migrate with the latter through the solid carrier as far as a second zone, where a further reagent is bound which also specifically recognizes either the analyte or the antibody/antigen.
  • the binding of the analyte-antibody/analyte-antigen reaction product in the second zone means that the analyte can be detected, for example, by an accumulation of the markers, or by a chemical reaction triggered by the binding.
  • DE 200 21 659 U1 discloses a device in which samples of body fluid, in particular urine, are tested for a plurality of drugs of abuse simultaneously. Test strips are arranged on a test card, each strip being sensitive to a specific drug of abuse and having a visible limit value in order to indicate the presence or absence of a specific drug.
  • the container used has, at its upper end, a closure lid which has a slot of such a size that a test card with test strips can be fitted therein.
  • the test card can be inserted through the slot in such a way that one end is immersed in the urine sample to a predetermined depth, the visible result from each test strip being able to be seen by virtue of the transparency of the wall of the container without removing the test card from the container.
  • samples test “positive” it is necessary for the slotted lid to be replaced by a second, unslotted lid and to remove the test card from the container, in order then to be able to send the closed container to a certified laboratory.
  • a device for determining the presence and/or quantity of one or more analytes in a sample of human body fluid comprising a container for receiving a sample of body fluid, with an interior that is delimited by a base and by a circumferential surface, further comprising at least one test strip with an absorbent section and with reagents for determining the presence and/or quantity of one or more analytes in the sample of body fluid, and comprising a holding element for receiving and holding the one or more test strips, said holding element having a shape corresponding and adapted to the peripheral circumferential surface of the container;
  • the device according to the invention further comprises an elongate sampling element which, at one of its ends, has an absorbent sampler that takes up the sample of body fluid, which sampling element can be inserted into the container, via its end comprising the sampler, in order to transfer the sample of body fluid into the container, and in that the base of the container has a central elevation or protrusion via which the sample of body fluid can be
  • the elongate sampling element and the absorbent sampler provided thereon it is possible, by interaction with the elevation provided on the base of the container, for the sample of body fluid, for example saliva, which has been taken up into the absorbent sampler, to be squeezed out in the container and to be conveyed to the absorbent sections of the test strips present in the container; almost the whole sample that has been taken up is utilized in this process, with the result that only relatively small quantities of the sample are needed.
  • body fluid for example saliva
  • the elongate sampling element which comprises a sampler at one of its ends, can be used to collect a sample of saliva, for example, from a person's mouth or throat, i.e., the nature of the absorbent sampler is such that the saliva is sucked up by the sampler.
  • the material from which the sampler is made can be any absorbent material, preferably a material with cotton-like or sponge-like properties, which, when squeezed out or pressed out, allows the sample contained therein to easily emerge from the material and additionally does not alter the composition of the saliva. It is within the competence of a person skilled in the art to provide a material suitable for these purposes.
  • the sampling element comprising the sampler, fully soaked with saliva for example, is then placed into the container, where it is pressed onto the elevation provided centrally on the base of the container, and the liquid sample, for example saliva, contained in the sampler is thus squeezed out.
  • the sample then flows across the elevation to the side edge at the base of the container, where the absorbent section of the at least one test strip is located and takes up the sample by capillary forces.
  • the sample then migrates across or up the test strip, as a result of which any analytes present in the sample can be detected in the manner described above.
  • an easy-to-use test appliance is thus made available which is also suitable for testing samples of saliva and with which the analytes that are to be detected in a sample can be detected rapidly.
  • the centrally arranged elevation also ensures that the sample contained in the sampler is squeezed out uniformly and is guided uniformly to the peripheral inner edge of the container.
  • the absorbent sections of the one or more test strips present there are thus supplied uniformly with the sample.
  • an “elongate” sampling element signifies any stick- or rod-shaped element that is suitable for being gripped at its one end by the person being tested or by a third party, such that the other end can be inserted into the mouth/throat in order to collect a sample of saliva, for example.
  • the sampling element according to the invention therefore has an end at which the sampler is provided and a gripping end, as well as an elongate, stick- or rod-shaped section lying in between. It will be appreciated, however, that the sample is not limited to a sample of saliva, since the sampling element can also be dipped into another receptacle containing the liquid sample, as a result of which the sampler can likewise be fully impregnated with the sample.
  • the sample that has been taken up in this way is then guided into the container, as has been described above, and the test for determining the presence or quantity of an analyte is started by squeezing the sample out from the sampler and bringing the test strips into contact with the sample.
  • the sampling element and/or the sampler are provided with at least one means that indicates that, and whether sufficient, liquid sample, in particular saliva, has been taken up.
  • the at least one means is an indicator strip of an absorbent material that is present in the sampling element and has at least one zone which lies away from the sampler and in which it is indicated when sufficient liquid sample, in particular saliva, is present by the colour of the material changing.
  • the absorbent material is in this case preferably a material comprising cellulose and makes it possible for the liquid sample to be able to migrate through or across the indicator strip and arrive in the zone in which the change in colour is observed.
  • the change in colour of the material may comprise a darkening of its colour that is brought about by the liquid sample taken up by and migrating across the material.
  • the change in colour may take place by a reaction of the material with the liquid sample in the manner of a pH indicator paper, according to which the material changes its colour, or takes on a colour if the material was previously colourless, at least in the zone.
  • the indicator strip either undergoes a change in colour as a whole when the liquid sample migrates across or through the indicator strip, or else only in the zone on the basis of which the presence of a sufficient amount of liquid sample is indicated.
  • the zone is correspondingly impregnated, or has a different composition than the rest of the material of the indicator strip.
  • the sampling element may be provided with a marking, for example in the form of a line or a notch, which is intended to serve as an indication as to how far the front of the liquid sample must travel across the indicator strip present in the sampling element to ensure the presence of a sufficient amount of liquid sample in the sampler. It will be appreciated that in the case of this embodiment the indicator strip as a whole can be seen.
  • the indicator strip by means of which it is indicated when sufficient liquid sample is present may, for example, be arranged in a—cross-sectionally—U-shaped recess in the rod-shaped section of the sampling element, and protrude with one of its ends into the sampler, which comprises a sponge-like material, or be received therein. This allows the liquid sample that is received by the sampler to reach the indicator strip and migrate across the indicator strip by capillary forces.
  • the elevation is a hemispherical elevation with its highest point located centrally in the base of the container.
  • This measure has the advantage that the sample contained in the sampler can be easily squeezed out on the hemispherical elevation, after which the sample flows down the elevation, on account of the hemispherical shape of the elevation, and towards the edge of the base or to the site where the base merges into the circumferential surface.
  • the sample is taken up by the absorbent section of the at least one test strip, and the detection of the analyte on the test strip proceeds.
  • the space between the outer peripheral edge of the hemispherical elevation and the outer peripheral edge of the base, i.e., where the base meets the circumferential surface, is dimensioned such that the absorbent section of the test strip fits into this space.
  • the surface within this space can slope downwards to the edge of the base, so as to further promote the flow of the sample in the direction from the elevation down to the edge of the base.
  • the elevation comprises ridge-shaped elements that extend centrally from the elevation towards the base in order to convey the sample to the peripheral edge of the base of the container.
  • ridge-shaped is intended to signify any element that assists in the function of conveying the sample down from the elevation, in particular narrow, elongate elements fitted along the outer surface of the elevation, in the manner of ribs.
  • This measure has the advantage that the liquid sample is distributed in an improved and targeted manner about the peripheral edge of the base such that, if several test strips are arranged with their absorbent section at the peripheral edge, all the test strips are also supplied with a defined amount of sample.
  • the base of the container has a depression in the area of and extending around the circumferential surface, for the purpose of receiving the sample flowing down from the elevation.
  • This measure has the advantage that the saliva that flows down across the elevation, after the sampler has been squeezed out on the elevation, is collected and concentrated in a kind of groove or peripheral channel, such that the one or more test strips, which are arranged with their absorbent section in this depression or groove or channel, are supplied even more reliably with a sufficient amount of the liquid sample.
  • the at least one test strip, with its absorbent section taking up the sample is adapted to the shape of the depression.
  • the absorbent section of the one or more test strips is bevelled with a wedge shape and is provided with its pointed end protruding into the depression.
  • the sampling element at its end remote from the end with the sampler, has a closure means for closing the container after the sampling element has been introduced into the container.
  • the closure ensures that the test can proceed without the sample being disturbed or affected. Moreover, this also ensures the safe transport of the device, for example to prepare the device for introduction into a reading appliance or scanner without any danger of the sample escaping from the container.
  • the closure is advantageously at the same time the grip part of the sampling element, such that the latter can be securely held and safely handled via the closure.
  • the sample of saliva is thus collected by inserting the other end of the sampling element, i.e., the end comprising the sampler, into the mouth or throat and by taking up/absorbing the saliva located therein into the sampler, while the sampling element is handled via the other end with the closure, which at the same time can be used as a grip, specifically either by the person who is to be tested or by another person.
  • the closure means is a press-fit, clip-on, rotary or bayonet-fit closure or a sealing ring which interacts in each case with the container and/or the holding element and/or an insertion element.
  • the closure means can be constructed in one or more pieces, depending on the nature of the closure.
  • the closure means of the sampling element can interact with means provided on the corresponding parts of the container, in order to firmly close the container.
  • the upper end of the container i.e., the end that is intended to be closed, can have a mating thread, for example, in cases where the closure means of the sampling element has a threaded section.
  • the end of the sampling element may alternatively or additionally be provided with closure means which are inserted into the container, for example in the position in which the sampler is fixed on the rod-shaped section.
  • closure or fixing means on the sampling element can then interact with corresponding means in the holding element or in the container and/or with an insertion element for fixing the sampling element.
  • a grip element can also be provided with which, for example in the case of a rotary closure, the sampling element can be taken hold of and screwed into the container.
  • the closure means is provided with means which, after the sampling element has been introduced into the container, block the removal of the sampling element from the container.
  • the means in question is a locking means that prevents the sampling element from being screwed out or pulled out after it has been introduced into the container.
  • sample the sample located in the container can also be used for further tests.
  • B-sample the competent authority, or the person carrying out the test, can be assured that the sample present in the container is unadulterated, that is to say is in the state in which it was removed from the test subject. It can then be safely used for further tests.
  • the sampling element can therefore be constructed such that a closure section, for example a rotary closure section, is connected to what is by comparison a thinner, elongate, rod-shaped section, which in turn is connected by its other end to the absorbent sampler.
  • the length of the sampling element is such that, when the element is introduced into the container and the container is closed, the absorbent sampler is either in a compressed state or in an uncompressed state, but the container as a whole is closed. In the compressed state, the user has to apply pressure to the sampler in order to close the container; in the uncompressed state, the sampler has to be first squeezed out in order to carry out the test, after which the container can then be closed without pressure being applied to the sampler.
  • the closure means has a pierceable, self-sealing element which, after it has been pierced, permits access to the interior of the container even after the closure means has been fitted onto the container.
  • This measure has the advantage that, when it is necessary to carry out further tests using the originally collected sample, it is possible to have simple and quick access to this original sample, specifically by a syringe or cannula or a similarly shaped and tapered sampling means being passed through the film-like element such that the latter is pierced, and the syringe/cannula/sampling means being used to remove some of the unused sample for further tests.
  • the container is a cylindrical container with a circular base.
  • the container is a cuboid container with a rectangular base.
  • This embodiment has the advantage that it can, for example, be read out by means of a scanner, since the planar sides of the container make uniform reading possible.
  • a shape of the holding element that is adapted “to the shape of the circumferential surface” should be understood as meaning that the shape of the holding element or the holding element is adapted peripherally to the shape of the circumferential surface forming the inner side of the container such that that it covers the entire peripheral inner circumference of the circumferential surface.
  • the circumferential surface is designed as a—hollow—cylinder, in particular a circular or angular cylinder
  • the holding element is also designed as cylindrical, in particular circular-cylindrical or angular-cylindrical. It will be appreciated that the holding element does not necessarily also cover the entire height of the cylinder. Accordingly, the holding element is designed as a hollow cylinder which is adapted to the inner cylindrical shape of the circumferential surface.
  • the holding element bears at least partially on the inner face of the circumferential surface of the container.
  • the bearing of the holding element on the inner face of the circumferential surface thus prevents direct contact between the liquid sample and that part of the test strip that contains the reagents. In this way, only that part of the test strip not containing any reagents comes into direct contact with the liquid sample. Some of the sample is then drawn by capillary forces in the longitudinal direction of the test strips and into the area of the reagents. This prevents contamination of the liquid sample, which is why the sample can be sent to a laboratory for further tests without taking out the test strips.
  • the holding element is at least partially spaced apart from the inner face of the circumferential surface of the container.
  • the spacing apart of the holding element is advantageous, since this facilitates contact between the sample to be tested and the test strips.
  • the holding element is shaped with pretensioning and clamped into the container.
  • the pretensioning of the holding element permits a good clamp fit within the container and prevents slipping of the holding element and of the test strips arranged therein. This is in turn important for preventing contamination of the sample by the reagents arranged on the test strips.
  • the holding element is at least partially bonded to the container, in particular to the inner face of the circumferential surface and/or of the base.
  • the bonding of the holding element to the container can prevent slipping of the holding element and thus prevent contamination of the sample.
  • the holding element prefferably fitted through a guide means arranged on the base of the container.
  • a guide means on the base of the container has the advantage that the holding element can be inserted more easily and thus more quickly into the container during production.
  • the holding element has recesses in which the test strips are respectively arranged.
  • the recesses allow the test strips to be fitted in place and prevent slipping of the test strips inside the holding element, that is to say in the longitudinal direction of the test strips.
  • the recesses are separated by webs, which bear at least partially on the inner face of the circumferential surface of the container.
  • the separation by webs arranged between the individual test strips prevents contact between the reagents of the various test strips.
  • the webs can prevent the liquid sample from getting into that area of the test strips where the reagents are arranged, such that the liquid sample can reach only the lower free end of the test strips where there are no reagents present. This therefore prevents contamination of the sample itself and ensures that the individual test strips and their reagents do not influence one another.
  • At least part of the circumferential surface of the container has a transparent area in the region of the test strips. It is thus possible to ensure that there is a direct optimal view of the test strips and that the result can be read off without removing the holding unit.
  • the holding element has a darker colour compared to the test strips.
  • This measure has the advantage of making it much easier to read off the test result on the test strip, since the contrast between the then brighter test strip and the holding element is greater than if the holding element is the same colour as or brighter than the at least one test strip.
  • the liquid sample to be tested can be any liquid sample of a body fluid from a human- or mammal in general—preferably saliva.
  • the transparent area is concealed by an at least partially detachable covering element, in particular by a film that cannot be seen through.
  • the covering element affords the advantage of preventing the test results from being read off by the subject or by other unauthorized persons.
  • the size of the covering element is chosen such that the area of the circumferential surface adjacent to the base is not concealed by the covering element. Through the uncovered area remaining at the lower end of the circumferential surface, the person carrying out the test can identify directly whether the liquid sample to be tested is present in the container in a sufficiently large quantity to permit contact with the test strips.
  • a cover element in particular a protective film, covers the test strips arranged in the recesses of the holding element.
  • the covering of the test strips, particularly in the area containing the reagents, is advantageous since it prevents direct contact between the liquid sample and the reagents present on the test strips.
  • the liquid sample thus comes into contact with the test strips only at the lower part of the test strips, where there are no reagents present.
  • Some of the liquid sample is then drawn by capillary forces into the area of the reagents. This in turn prevents contamination of the sample.
  • the device according to the invention can have between 1 and 12 test strips, in particular, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 test strips, which can each be used after insertion into the holding element. It is particularly preferable for the device to have at least six test strips.
  • an insertion element by means of which the sampling element can be inserted into the container is additionally provided.
  • the insertion element preferably has a hollow, substantially cylindrical shape, with an upper end, opposite from the base of the container, and a lower opening, facing the base.
  • the sampling element may be inserted into this insertion element via the upper end thereof, and reaches through the lower opening into the container, and can as a result be squeezed out on the elevation provided on the base.
  • the insertion element is either already inserted in the container—and as a result also in the holding element present therein—and only then is the sampling element inserted, or on the other hand the sampling element may have already been brought together with the insertion element before insertion into the container, and this assembled arrangement is inserted into the container.
  • the insertion element offers the advantage that additional fixing of the sampling element is made possible.
  • the insertion element may also have at the upper end two lateral flanges, which limit insertion of the insertion element by the flanges lying on the upper edge of the container.
  • the base of the container has means by which the sample of body fluid can be conveyed from the elevation to the side edges of the base, in particular the long side edges in the case of a rectangular base. This ensures that the sample of body fluid is conveyed from the elevation to the region into which the absorbent sections of the test strips protrude, and so starting of the test is ensured after the squeezing out.
  • these means are elevations which are provided at a distance from the elevation on which the sampler is squeezed out and in each case adjacent to the short side edges of the base.
  • the device according to the invention can be used for any type of test for a drug or for multiple drugs.
  • the sample of liquid can be tested at one and the same time for several drugs of abuse, including in particular amphetamines, barbiturates, benzodiazepines, cocaine, marihuana, methadone, methamphetamine, methylenedioxy-methamphetamine, morphine, opiates, oxycodone, phencyclidine, propoxyphene, tricyclic antidepressants, buprenorphine, cotinine, EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine) and fentanyl.
  • drugs of abuse including in particular amphetamines, barbiturates, benzodiazepines, cocaine, marihuana, methadone, methamphetamine, methylenedioxy-methamphetamine, morphine, opiates, oxycodone, phencyclidine
  • the analytes, in particular drugs, are preferably detected using an immunoassay based on the principle of competitive binding.
  • the test strip contains, for example on a test line, a membrane, for example a nitrocellulose membrane, coated with analyte (in particular drug)-protein conjugates (for example pure bovine serum albumin) and, on a control line, a polyclonal antibody (goat) against gold protein conjugate and a colour field with gold particles that are coated with specific monoclonal antibodies for the drugs to be detected and are immobilized in the test field. If drugs are present in the liquid sample, these compete with their conjugates for binding sites on their specific antibody.
  • analyte in particular drug
  • protein conjugates for example pure bovine serum albumin
  • the sample for example, urine or saliva
  • migrates “upwards” by capillary forces i.e., from the sample-receiving end of the test strip to the upper end of the test strip.
  • the drug-protein conjugates on the test strip go into solution and migrate with the sample to the test area of the corresponding drug detection strip.
  • Drugs that are contained in concentrations below the detection limit in the liquid sample, particularly saliva, do not saturate the binding sites of their specific antibodies immobilized in the test field, such that the antibodies in this case react with the conjugates, as a result of which a coloured line becomes visible. If the concentration of the drugs in the urine or the liquid sample is higher, the drug molecules drive the conjugates from the urine or occupy all the antibody binding sites, as a result of which no coloured line is formed.
  • the test strips can have a control area in which a coloured line appears each time the test is carried out, independently of any drugs possibly present in the urine or the liquid sample.
  • the following detection limits are provided for certain drugs: amphetamine: ca. 50 ng/ml and upwards; cocaine: 20 ng/ml and upwards; marihuana (tetrahydrocannabinol): ca. 20 ng/ml and upwards; methamphetamine 50 ng/ml and upwards; methylenedioxymethamphetamine: ca. 50 ng/ml and upwards; opiates: 40 ng/ml and upwards; phencyclidine: ca. 10 ng/ml and upwards.
  • test strips can be designed in one or more pieces.
  • “one or more pieces” means that the test strip can be formed in one section or from several interconnected, for example overlapping, parts which can be made of different or identical materials with different or identical dimensions.
  • one or more analytes can be detected on one or more test strips, that in addition control zones can also be provided for confirming that the test has been carried out completely and correctly, and that the strips can be preceded by samplers that serve, for example, to take up and forward the sample.
  • samplers serve, for example, to take up and forward the sample.
  • the test strips include an alcohol test.
  • the alcohol test makes it possible not only to test the sample for illegal drugs of abuse or other analytes, but also to combine this with detection of the alcohol content of the sample. In police checks in particular, this embodiment can thus provide a quick and simple indication that the subject is unfit to drive.
  • an alcohol content of at least ca. 0.04% is detected. It is preferable if the detection takes place by a reaction of the enzymes alcohol oxidase, peroxidase and an enzyme substrate, for example tetramethylbenzidine, in the presence of ethanol.
  • test strip for detection of alcohol it is advantageously only the actual presence of alcohol that is detected.
  • other measures can be taken in order also to determine the amount of alcohol present in the sample, for example a reaction providing a colour intensity which differs in intensity, in particular with an increasing alcohol content, and which can be read off on the basis of a scale that is also supplied.
  • the device comprises at least one test strip for detecting adulteration of the sample.
  • test strips for the adulteration tests include a colour reaction, which is then compared with colour fields on a colour scale.
  • colour scales can be supplied together with the device, such that the user himself can directly test for/detect adulteration. It is particularly preferable if the colour reaction is classed as “normal” (unadulterated sample) and “abnormal” (adulterated sample).
  • the container is a cylindrical container with a circular base and that the holding element has a curved shape adapted to the circular cross section of the circumferential surface.
  • the container is thus a round beaker, thus facilitating the insertion of the holding element and, later, the reading off of the test results.
  • the cylindrical container can preferably have a diameter of ca. 1 cm to ca. 15 cm, preferably of between ca. 1 cm and 5 cm.
  • FIG. 1 shows a schematic view of the individual elements of an embodiment of the device according to the invention, in the unassembled state, which device is used to test samples of body fluids.
  • FIG. 2 a shows a schematic view of the elements from FIG. 1 in the assembled state, without a covering.
  • FIG. 2 b shows a view as in FIG. 2 a , with partial covering of the test strips and containers.
  • FIG. 3 shows an enlarged perspective view of an embodiment of the base of the container of the embodiment shown in FIGS. 1 and 2 .
  • FIG. 4 shows a detail of the lower section of the container comprising the base of the embodiment shown in FIG. 3 , with the sampling element inserted into the container, and with the sampler in the compressed state on the elevation.
  • FIG. 5 shows a detail of the upper section, comprising the grip and the closure means, in one embodiment of the sampling element.
  • FIG. 6 shows a detail of an embodiment of the closure means, in engagement with means that are correspondingly provided in the container and are used to close the device.
  • FIG. 7 shows a detailed plan view of the sampling element of an embodiment of the device according to the invention with means for indicating a sufficient amount of liquid sample in the sampler.
  • FIG. 8 shows a further embodiment of a sampling element, in longitudinal section (A) and in an exploded representation (B).
  • FIG. 9 shows a further embodiment of the device according to the invention, the partially assembled form being shown in (A); the holding element removed from the container being shown in (B); the sampling element being shown in (C) and an insertion element for the sampling element being shown in (D).
  • FIG. 10 shows a cross section through the assembled embodiment shown in FIG. 9 .
  • FIG. 11 shows a plan view of the base of the container of the embodiment shown in FIGS. 9 and 10 .
  • FIG. 1 An embodiment of a device 10 according to the invention for testing samples of liquid is shown in FIG. 1 , where the individual elements of the device 10 are depicted, and the device 10 as a whole is in the unassembled state.
  • the device 10 comprises a container 12 , and a holding element 13 which is to be arranged in the container 12 and which holds one or, as is shown in FIG. 1 , several test strips 18 .
  • the test strips 18 have absorbent sections 19 via which the liquid sample is taken up and the test is thereby started on the test strip 18 .
  • the container 12 is cylindrical with a circular base 15 and with a roundly curved circumferential surface 16 .
  • the container 12 also comprises, at its upper end, a thread 17 which, by engagement with corresponding means, serves to close the container 12 .
  • the holding element 13 has lengthwise axial recesses 14 a , which are separated from one another by webs 14 b lying between the recesses 14 a .
  • the recesses 14 a and the webs 14 b are delimited at the top by a free surface of the holding element 13 .
  • the recesses 14 a of the holding element 13 continue as far as the bottom end thereof.
  • test strips 18 are inserted in the recesses 14 a of the holding element 13 .
  • the test strips 18 are inserted with an exact fit into the recesses 14 of the holding element 13 and are separated from one another by the webs 15 .
  • the test strip 18 is divided into a section 18 a , in which the test results can be read off, and a section 18 b , on which the name of the analyte that is to be tested is marked.
  • the section 18 a thus comprises the reagents which, by reacting with the analytes to be tested, are responsible for indicating a test result.
  • the fact that the shape of the holding element 13 matches the circumferential surface 16 , extending in the example shown in FIG. 1 peripherally over the entire inner circumference of the circumferential surface 16 means that the results can be read off very easily by sight.
  • the test strips 18 also have absorbent sections 19 via which the sample is taken up onto the test strip 18 .
  • FIG. 1 also shows the sampling element 20 .
  • the latter comprises, at its end to be inserted into the container 12 , a sampler 22 with which, for example, a sample of saliva can be taken from the mouth or throat.
  • the sampler 22 has a structure similar to cotton wool or sponge or is made of a material that is able to absorb and store liquid.
  • An elongate, rod-shaped section 23 connects the sampler 22 to the end section 24 which, in the embodiment shown in FIG. 1 , also comprises the grip 25 and the closure means 26 .
  • the closure means 26 shown in FIG. 1 is a rotary closure means, that is to say a thread which is provided on the end section and which, when the sampler 22 is inserted into the container 12 , engages with the mating thread 17 of the container 12 .
  • FIG. 2 a The elements of the embodiment of the device according to the invention shown in FIG. 1 are shown in the assembled state in FIG. 2 a .
  • the holding element 13 is inserted into the container 12 such that the absorbent sections 19 of the test strips 18 located in the holding element 13 are in contact with the base 15 of the container 12 .
  • the sampling element 20 is also introduced into the container 12 in such a way that the sampler 22 is inserted into the container 12 , and the closure means 26 engages with the mating thread 17 of the container 12 in order to close the container 12 .
  • FIG. 2 b shows the same embodiment as in FIG. 2 a , with the additional feature of a partial covering element 27 of the test strips 18 .
  • This covering element 27 is applied, for example by adhesive bonding, to the outer surface of the container 12 , specifically below the area 18 a , that is to say the area where the test results are indicated.
  • the covering element 27 can, for example, carry instructions on how the test results are to be evaluated, for example to the effect that, if a band appears in the area 18 a of the test strip 18 , the subject has tested positive to a specific analyte (“pos”), or, if two bands appear in the area 18 a , the subject is negative (“neg”) with respect to the analyte, and, if no band can be seen in the area 18 a , the test is invalid (“invalid”).
  • pos specific analyte
  • neg negative
  • the circumferential surface 16 of the container 12 can have a section 28 not covered by the covering element 27 .
  • This uncovered section 28 offers the possibility, for example, of checking whether the liquid sample to be tested is present in a sufficient quantity.
  • the holding element 13 can be darker compared to the colour of the test strips 18 , which makes the test result easier to read off in the area 18 a , since the darker colouring makes the contrast to the test strip greater than would be the case with a brighter coloured holding element 13 .
  • the whole container 12 can also be provided on its outer surface with a covering element and that in the area 18 a , i.e., where the test result is read off, there is an area in which the covering element can be detached from the container such that the test result and the area 18 a of the test strips can be seen from the outside.
  • the covering element can, for example, be adhesively bonded to the outer surface of the container, the adhesive selected for the area that is to be detached, to allow the test results to be read off, being a more easily releasable adhesive than the one selected for the areas that remain on the surface of the container.
  • FIG. 3 shows an enlarged view of the internal design of the base 15 of the container 12 , the side wall of the container 12 having been cut away to show the design of the base.
  • the base 15 has an elevation 30 in the form of an opened hemisphere, the latter being arranged centrally on the base 15 , with its curvature pointing in the direction of the other end of the container 12 .
  • the elevation 30 also comprises ridge-shaped elements 32 which, starting from the highest point of the elevation 30 , are routed down the sides thereof.
  • the base 15 further comprises a depression or sample-collecting channel 34 which is formed all round the edge to the circumferential surface and which collects the sample running down from the elevation 30 and guided from the latter by the ridge-shaped elements 32 .
  • the absorbent sections 19 of the test strips 18 are received in this depression or sample-collecting channel 34 , such that the sample located in the sample-collecting channel 34 can be taken up by the absorbent sections 19 into the test strips 18 by capillary forces, and the test for determining the analyte or analytes can proceed on the one or more test strips 18 .
  • FIG. 4 shows a view in which the end of the sampling element 20 comprising the sampler 22 is pressed onto the elevation 30 of the base 15 of the container 12 .
  • the sample that has been taken up by the sampler 22 and stored therein is thus squeezed out on the elevation 30 and runs down the side of the latter into the sample-collecting channel 34 .
  • the flow of the sample down from the elevation is additionally promoted by the ridge-shaped elements 32 provided on the elevation 30 , and these elements 32 aid the uniform distribution of the sample in the circumferential sample-collecting channel 34 .
  • test strip 18 introduced into the holding element 13 protrudes with its absorbent end 19 into the sample-collecting channel 34 .
  • FIG. 5 shows in detail an embodiment of the end of the sampling element 20 that comprises the grip 25 and/or the closure means 26 .
  • a B-sample container 36 is provided centrally in the head of the sampling element 20 and has a closure cap 38 that is to be firmly closed and that cannot be opened again without this leaving a sign that it has been opened.
  • the closure cap 38 has closure lamellae 39 extending around its side, and a self-sealing, pierceable sampling element 40 via which, for example, material for the B-sample can be removed using a syringe or cannula, as is shown schematically by the partially depicted syringe tip 42 .
  • FIG. 6 shows an enlarged view of the end of the sampling element 20 comprising the closure means 26 .
  • the outermost end section forms a kind of grip 25
  • the closure means 26 are designed in the form of a thread, which engages in a mating thread 17 provided on the container 12 .
  • the mating threaded piece designated by 44 in FIG. 6 has a catch 46 which, when actuated, secures the mating thread 17 .
  • the catch 46 can be made particularly noticeable by a corresponding marking or a corresponding indicator on the outer container, in order to indicate the possibility of monitoring.
  • FIG. 7 shows a detailed view of a further embodiment of a sampling element 44 of the device 10 according to the invention.
  • the sampling element 44 likewise has a sampler 51 , a rod-shaped section 52 and a grip 53 .
  • the rod-shaped section 52 also has a U-shaped recess 54 —seen in cross section—in which an indicator strip 46 for indicating the presence of an amount of liquid sample sufficient for carrying out the assay is inserted.
  • the indicator strip 46 protrudes with one of its ends 47 into the sampler 51 , making it possible for liquid sample that is taken up by the sampler 51 to get into the indicator strip 46 of an absorbent material.
  • the liquid sample then migrates through the indicator strip 46 as far as a specific zone 48 of the indicator strip 46 that lies at a specific distance away from the sampler 51 in the rod-shaped section 52 of the sampling element 44 , and by means of which zone 48 it can be established that a sufficient amount of liquid sample is present in the sampler 51 .
  • This zone 48 may be provided with specific indicating means by which it can be established, for example by means of a colour reaction, when the liquid sample enters the zone 48 that there is sufficient sample to be able to carry out the assay.
  • the rod-shaped section 52 of the sampling element 44 has a marking, for example at the level of the zone 48 , which indicates the minimum travelling distance of the liquid sample on/through the indicator strip.
  • the marking may be, for example, a line or a notch in the rod-shaped section 52 .
  • FIG. 8 A further embodiment of the sampling element 60 is shown in FIG. 8 , FIG. 8A showing a longitudinal section through the sampling element 60 , and FIG. 8B showing an exploded representation of the individual parts or sections of the sampling element 60 .
  • said sampling element likewise has a sampler 61 , as well as an elongate, rod-shaped section 62 and an end section 64 , which comprises a grip 63 and closure means 65 .
  • the elongate, rod-shaped section 61 , and the end section 64 including the grip 63 and the closure means 65 are formed in one piece in the embodiment shown in FIG. 8 , in the form of a hollow rod 67 with a holding grip, which can be seen in particular in FIG. 8B .
  • the sampler 61 a sponge-like element, is fastened to the end of the rod 67 that is to be inserted into the container 12 .
  • An insertion element 68 which has a U-shaped recess 69 —seen in cross section—into which an indicator strip 66 can be inserted or placed, can be inserted into the rod 67 .
  • the rod 67 is in this case produced from a transparent material, so that, after insertion of the insertion element 68 and the indicator strip 66 lying therein into the hollow rod 67 , it can be read off from the indicator strip whether and when sufficient liquid sample has been taken up by means of the sampler 61 .
  • FIG. 9 A further embodiment of the device 70 according to the invention or parts thereof is shown in FIG. 9 , with a container 72 and a holding element 73 arranged therein ( FIG. 9A ), which is also shown separately in FIG. 9B .
  • the holding element 73 has a hollow angular-cylindrical shape, which is adapted to an inner circumferential surface 76 of the container 72 , so that the holding element 73 can be inserted into the container 72 such that it fits.
  • the base 75 of the device 70 is of a substantially rectangular design, corresponding to the circular-cylindrical shape of the circumferential surface 76 .
  • the holding element 73 has recesses 74 a and webs 74 b lying between the recesses 74 a , both being delimited in a top section of the holding element 73 that is facing the open end of the container 72 , and formed continuously as far as the end that in the inserted state is facing the base 75 of the container 72 .
  • Test strips which are not shown in FIG. 9 for reasons of clarity, may be inserted in the recesses 74 a .
  • the lower end 77 of the holding element 73 facing the base 75 of the container 72 ends at a specific distance from the base 75 , so that the test strips present in the recesses 74 a protrude with an absorbent section out of the holding element 73 and the recesses 74 a such that that they come into contact with the liquid sample that is preferably present between the base 75 at the lower end 77 of the holding element 73 , or are immersed in the sample.
  • the end 77 of the holding element also has centrally a holding element opening 76 (see FIG. 10 ), which is dimensioned such that the sampling element 80 can be guided with its sampler 82 through the holding element opening 76 to the elevation (not shown in FIG. 9 ) present on the base 75 and squeezed out on it.
  • the holding element opening 76 is preferably substantially round or adapted for receiving and leading through the lower end 94 of the insertion element 90 .
  • FIG. 9C Shown in FIG. 9C is an embodiment of the sampling element 80 which can be used in the case of the embodiment of the device 70 shown in FIG. 9 and which corresponds substantially to the embodiment of the sampling element shown in FIG. 8A and FIG. 8B .
  • the sampling element 80 has a sampler 82 , an absorbent, sponge-like element by means of which the sample is taken up, as well as a rod-shaped section 83 , and an end section 84 , which in turn has a grip 85 and closure means 86 .
  • the closure means are a peripheral sealing ring which interacts with an opening 92 in an insertion element 90 that is represented in FIG. 9D when the sampling element 80 is inserted into the opening 92 in the insertion element 90 .
  • the sealing ring engages in the opening 92 in a sealing manner, so that slipping of the sampling element 80 out of the insertion element 90 is avoided.
  • the insertion element 90 shown in more detail in FIG. 9D has a substantially hollow cylindrical shape, with an opening 92 at the end by which the sampling element 80 is inserted, and with an open end 94 , from which the sampler 82 is at least partially led out in the direction of the base 75 of the container 72 and, as a result, can be pressed onto an elevation (not shown in FIG. 9 ) provided on the base 75 of the container 72 and squeezed out.
  • FIG. 10 shows a cross section of the assembled device 70 from FIG. 9 , i.e., the device 70 in which the sampling element 80 has been inserted, or is in the process of being inserted, together with the insertion element 90 into the container 72 in which the holding element 73 is also already arranged.
  • the base 75 of the container 72 is provided with an elevation 79 onto which the sampler 82 can be compressed.
  • further means may be provided, interacting with fixing means, for example a thread inside or on the inner side of the container or the holding element, in order to bring about fixing of the sampling element.
  • the elevation 79 represented in FIG. 10 may likewise have ridge-shaped ribs, which however are not represented in FIG. 10 for better clarity.
  • the holding element 73 is inserted into the container 72 . Access to the elevation 79 on the base 75 of the container 72 is ensured by the holding element opening 76 provided in the lower end of the holding element. This can be followed by inserting the insertion element 90 which, as can be seen in FIG. 9D , has two lateral flanges or a peripheral edge which comes to lie on the upper edge of the container 78 (see FIG. 9A ) and thereby limits the insertion of the insertion element 90 into the container 72 .
  • the insertion element 90 which is of a substantially cylindrical design, has at the lower end, facing the base 75 of the container 72 , the open end 94 , through which access to the elevation 79 on the base 75 of the container 72 is ensured for the sampler 82 that is to be squeezed out on it. Insertion of the sampling element 80 has the effect that the end section 84 seals off the opening 92 in the insertion element 90 in a sealing manner by means of the sealing ring 86 and thereby closes the device 70 . At the same time, the sampler 82 is compressed on the elevation 79 , so that the sample previously taken up in it, in particular saliva sample, is squeezed out on the elevation 79 .
  • FIG. 11 A plan view of the base 75 of the container 72 is shown in FIG. 11 , the peripheral circumferential surface 76 not being represented for reasons of clarity.
  • a hemispherical elevation 79 onto which the sampler 82 can be squeezed out.
  • lateral elevations 81 a and 81 b which are formed at a distance from the elevation 79 and adjoining the short side walls of the substantially rectangular base 75 .
  • the sample or saliva running off over the elevation 79 is respectively guided laterally to the long side edges of the base 75 , as shown by the arrows 98 a and 98 b .
  • the absorbent sections of the test strips 18 protrude into these side edges of the base 75 , so that the sample can reach the test strips via these absorbent sections and the test can thereby be started.
  • the container is made of a transparent material, preferably plastic, in order to be able to read off the test result on the test strips 18 visually or mechanically with a scanner.
  • the device is not limited to the embodiments described above.
  • the number of test strips can vary as required, and the structure of the container is also variable and does not necessarily have to be in the form of a container with a circular cross section.
  • the configuration of the holding element can also differ from the one described in the embodiments.
  • the semicircular, curved shape illustrated here it is possible in particular for the holding element to have a tubular shape and thus bear about the full circumference of the circle on the inner face of the circumferential surface.
  • the lid of the container to be replaced by another closure element, in particular by a closable flap.
  • the cover element too is not limited to a three-part structure, and instead it can also be in the form of a multi-part or just one-part or two-part cover element.
  • the device according to the invention can be used for any type of test for a drug or for multiple drugs.
  • the sample of fluid can be tested at one and the same time for several drugs, including amphetamines (AMP 1000), barbiturates (BAR 300), benzodiazepines (BZD 300), cocaine (COC 300), marihuana (THC 50), methadone (MTD 300), methamphetamine (MET 1000), methylenedioxy-methamphetamine (MDMA 500), morphine (MOR 300), opiates (OPI 2000), oxycodone (OXY 100), phencyclidine (PCP 25), propoxyphene (PPX 300), tricyclic antidepressants (TCA 1000), buprenorphine (BUP 10), cotinine (COT 200 ), EDDP (EDDP 100) and fentanyl (FYL 10).
  • An alcohol test and at least one adulteration test can be integrated into the device.
  • the main advantages of the invention are the simple handling of the device according to the invention and the possibility of being able to send the sample to a certified laboratory without exchanging any elements and without removing the test strips. This permits quick, hygienic and more reliable implementation of the test and does not require any special knowledge on the part of the person conducting the test.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
US13/211,208 2009-02-16 2011-08-16 Device for assaying analytes in bodily fluids Abandoned US20120094303A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/625,608 US9462998B2 (en) 2009-02-16 2012-09-24 Device for assaying analytes in bodily fluids
US14/500,230 US9414813B2 (en) 2009-02-16 2014-09-29 Device for assaying analytes in bodily fluids
US15/290,503 US10076314B2 (en) 2009-02-16 2016-10-11 Device for assaying analytes in bodily fluids
US16/131,742 US20190083069A1 (en) 2009-02-16 2018-09-14 Device for assaying analytes in bodily fluids

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102009010563A DE102009010563A1 (de) 2009-02-16 2009-02-16 Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
DE102009010563.8 2009-02-16
PCT/EP2010/000948 WO2010091897A1 (de) 2009-02-16 2010-02-16 Vorrichtung zum nachweis von analyten in körperflüssigkeiten

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/000948 Continuation WO2010091897A1 (de) 2009-02-16 2010-02-16 Vorrichtung zum nachweis von analyten in körperflüssigkeiten

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/625,608 Continuation US9462998B2 (en) 2009-02-16 2012-09-24 Device for assaying analytes in bodily fluids

Publications (1)

Publication Number Publication Date
US20120094303A1 true US20120094303A1 (en) 2012-04-19

Family

ID=42115416

Family Applications (5)

Application Number Title Priority Date Filing Date
US13/211,208 Abandoned US20120094303A1 (en) 2009-02-16 2011-08-16 Device for assaying analytes in bodily fluids
US13/625,608 Active 2031-02-23 US9462998B2 (en) 2009-02-16 2012-09-24 Device for assaying analytes in bodily fluids
US14/500,230 Expired - Fee Related US9414813B2 (en) 2009-02-16 2014-09-29 Device for assaying analytes in bodily fluids
US15/290,503 Expired - Fee Related US10076314B2 (en) 2009-02-16 2016-10-11 Device for assaying analytes in bodily fluids
US16/131,742 Abandoned US20190083069A1 (en) 2009-02-16 2018-09-14 Device for assaying analytes in bodily fluids

Family Applications After (4)

Application Number Title Priority Date Filing Date
US13/625,608 Active 2031-02-23 US9462998B2 (en) 2009-02-16 2012-09-24 Device for assaying analytes in bodily fluids
US14/500,230 Expired - Fee Related US9414813B2 (en) 2009-02-16 2014-09-29 Device for assaying analytes in bodily fluids
US15/290,503 Expired - Fee Related US10076314B2 (en) 2009-02-16 2016-10-11 Device for assaying analytes in bodily fluids
US16/131,742 Abandoned US20190083069A1 (en) 2009-02-16 2018-09-14 Device for assaying analytes in bodily fluids

Country Status (6)

Country Link
US (5) US20120094303A1 (de)
EP (2) EP2395921B1 (de)
CA (1) CA2752700A1 (de)
DE (1) DE102009010563A1 (de)
ES (1) ES2524479T3 (de)
WO (1) WO2010091897A1 (de)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014078451A1 (en) * 2012-11-13 2014-05-22 Premier Biotech, Inc. Screening device for analysis of bodily fluids
US20160066895A1 (en) * 2013-04-30 2016-03-10 Microtri Limited Bodily Fluid Specimen Collection and Assay Device
US20160243544A1 (en) * 2013-11-14 2016-08-25 Abon Biopharm (Hangzhou) Co., Ltd. A device and method for using the device
US20160273059A1 (en) * 2013-10-22 2016-09-22 Ilex Medical Ltd. Kit and method for collecting body fluid for medical diagnosis
WO2017083843A1 (en) * 2015-11-13 2017-05-18 Dnt Scientific Research, Llc Driven flow and volumetric control devices and methods
US20170143314A1 (en) * 2015-10-19 2017-05-25 Green Panther Ventures Urine Sampling Vessel
USD790074S1 (en) * 2012-11-13 2017-06-20 Premier Biotech, Inc. Saliva test device
JP6192196B1 (ja) * 2016-03-15 2017-09-06 積水メディカル株式会社 検査容器及びそれを用いた検査方法
WO2017159616A1 (ja) * 2016-03-15 2017-09-21 積水メディカル株式会社 検査容器及びそれを用いた検査方法
CN109342708A (zh) * 2018-11-09 2019-02-15 广州浩强生物科技有限公司 一种唾液检测装置
CN110074823A (zh) * 2019-05-31 2019-08-02 万华普曼生物工程有限公司 唾液采检装置
CN110192898A (zh) * 2019-05-31 2019-09-03 万华普曼生物工程有限公司 唾液采检装置
CN110361549A (zh) * 2019-08-16 2019-10-22 贵州大学 一种可多次检验的验孕装置
US20200383664A1 (en) * 2019-02-14 2020-12-10 Marshall Venture Partners LLC Systems and methods for fluid sample collection and testing
US20210307729A1 (en) * 2018-11-13 2021-10-07 Procisedx Inc. Fecal sampler
US20210308667A1 (en) * 2020-04-06 2021-10-07 Charm Sciences, Inc. Unit device, method, and assembly
WO2021263003A1 (en) * 2020-06-24 2021-12-30 President And Fellows Of Harvard College Automatic multi-step reaction device
US20220023858A1 (en) * 2013-05-24 2022-01-27 Premier Biotech, Inc. Multi-stage oral-fluid testing device

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009010563A1 (de) * 2009-02-16 2010-08-26 Matthias W. Engel Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
CA2728379C (en) * 2009-03-04 2016-06-14 John Wan Collection and assay device for biological fluid
EP2722669A1 (de) * 2012-10-22 2014-04-23 Securetec Detektions-Systeme AG Verfahren und Vorrichtung zum Nachweis von illegalen Drogen
DE202014002369U1 (de) 2013-03-23 2014-04-29 Ingenieurbüro Protzek & Kollegen Gbr(Vertreten Durch Den Gesellschafter: Christoph Protzek,79539 Lörrach) Gerät zum Nachweis von Analyten in einer flüssigen Probe
JP6588082B2 (ja) 2014-04-11 2019-10-09 プレジデント アンド フェローズ オブ ハーバード カレッジ ソフトマシンの大量生産法
MX2016011866A (es) 2014-04-25 2017-05-10 Siemens Healthcare Diagnostics Inc Unidad de recoleccion de muestras.
US20160074018A1 (en) * 2015-11-23 2016-03-17 Michelle Marie Lependorf Urine Specimen Collection Kit With Retractable/Adjustable Handle and Sponge
US9632083B1 (en) 2016-04-15 2017-04-25 Dnt Scientific Research, Llc Rapid diagnostic test device by driven flow technology
US9702872B1 (en) 2016-04-15 2017-07-11 Dnt Scientific Research, Llc Rapid diagnostic test device by driven flow technology
US9535061B1 (en) * 2016-06-29 2017-01-03 Dnt Scientific Research, Llc Multi-functional rapid diagnostic test device
CN108093453B (zh) * 2016-11-21 2020-03-03 北京小米移动软件有限公司 小区重选方法及装置
CN106645663B (zh) * 2017-01-22 2023-07-18 英科新创(厦门)科技股份有限公司 一种防污染垂直层析检测装置
CN107238697B (zh) * 2017-04-13 2019-04-16 杭州旭科生物技术有限公司 一种收集并检测样本的方法
US11712200B2 (en) 2017-04-28 2023-08-01 University of Pittsburgh—of the Commonwealth System of Higher Education Nanostructure-based cannabinoid sensor
KR102582297B1 (ko) 2017-05-19 2023-09-25 필립모리스 프로덕츠 에스.에이. 대상체의 흡연 상태를 구별하기 위한 진단 테스트
US9784733B1 (en) 2017-06-22 2017-10-10 Dnt Scientific Research, Llc Rapid diagnostic test device by driven flow technology
RU175853U1 (ru) * 2017-07-18 2017-12-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Устройство для экспресс-анализа ротовой жидкости
US9823244B1 (en) 2017-07-31 2017-11-21 Dnt Scientific Research, Llc Digital progressive compression driven flow cartridge for analyte detecting device and method
US11234682B2 (en) * 2018-09-28 2022-02-01 Zhejiang Orient Gene Biotech Co., Ltd. Apparatus for detecting analyte in a liquid sample
US10451613B1 (en) 2018-11-09 2019-10-22 Dnt Scientific Research, Llc Rapid diagnostic test device and sampling method using driven flow technology
US11724255B2 (en) 2019-02-14 2023-08-15 Marshall Venture Partners LLC Systems and methods for fluid sample collection and testing
DE102019117289A1 (de) 2019-06-27 2020-12-31 Katja Werner Trägermaterial, Kitsystem und Verfahren für biologische Assays
IL268395A (en) * 2019-07-31 2021-01-31 Katz Emil System and method for collecting, sampling, growing and testing liquids
NO345834B1 (en) * 2019-12-02 2021-08-30 Restone As A shear bond strength sample preparation device, a shear bond strength test sample, a shear bond strength sample testing system, and a method of testing shear bond strength of a test sample in shear bond strength sample testing system.
WO2021168469A1 (en) * 2020-02-05 2021-08-26 Marshall Venture Partners LLC Systems and methods for fluid sample collection and testing
EP4125614A4 (de) * 2020-03-27 2024-07-17 Marshall Venture Partners LLC Systeme und verfahren zur flüssigkeitsprobenentnahme und -prüfung mit einer abstrichanordnung mit integrierten lateralflussteststreifen
WO2021236050A1 (en) 2020-05-18 2021-11-25 Baseline Global, Inc. Assay device, system, method, and kit
FR3121515A1 (fr) * 2021-04-02 2022-10-07 Ng Biotech Dispositif pour l’analyse rapide d’un échantillon biologique, par exemple un échantillon biologique salivaire
WO2022207890A1 (fr) * 2021-04-02 2022-10-06 Ng Biotech Dispositif pour l'analyse rapide d'un échantillon biologique, par exemple un échantillon biologique salivaire
FR3121514A1 (fr) * 2021-04-02 2022-10-07 Ng Biotech Dispositif pour l’analyse rapide d’un échantillon biologique, par exemple un échantillon biologique salivaire
DE102021115185A1 (de) 2021-06-11 2022-12-15 Universität Heidelberg Körperschaft des öffentlichen Rechts Probennahmesystem zur Eigenentnahme einer Salivaprobe

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190259A1 (en) * 2001-10-05 2003-10-09 Alley Kenneth A. Apparatus for sampling, storing, preserving and testing a specimen
US7927562B2 (en) * 2007-12-13 2011-04-19 W.H.P.M. Inc. Collection and assay device for biological fluid
US8163253B1 (en) * 2004-08-03 2012-04-24 Hartselle R Lawrence Method for collecting, storing, transporting and assaying a specimen

Family Cites Families (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US872357A (en) 1907-04-01 1907-12-03 Mapother Kerr And Lerch Combined package seal and fastener.
US5622871A (en) 1987-04-27 1997-04-22 Unilever Patent Holdings B.V. Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
US3641235A (en) 1968-11-01 1972-02-08 Miles Lab Immunological reagent and process for making same
US3966897A (en) 1973-04-02 1976-06-29 Marine Colloids, Inc. Medium for use in bioassay and method of using same
US3959078A (en) 1973-05-18 1976-05-25 Midwest Research Institute Enzyme immobilization with a thermochemical-photochemical bifunctional agent
SE388694B (sv) 1975-01-27 1976-10-11 Kabi Ab Sett att pavisa ett antigen exv i prov av kroppvetskor, med utnyttjande av till porost berarmaterial bundna eller adsorberande antikroppar
DE2601794C3 (de) * 1976-01-20 1979-01-11 Riedel-De Haen Ag, 3016 Seelze Vorrichtung zum Nachweis von okkultem Blut
IL52322A (en) 1976-06-18 1980-10-26 Alfa Laval Ab Method of making reagent test device and device made accorording to this method
US4094647A (en) 1976-07-02 1978-06-13 Thyroid Diagnostics, Inc. Test device
JPS55162059A (en) 1979-06-05 1980-12-17 Mochida Pharmaceut Co Ltd Measuring method for antigen, antibody or their complex and measurement reagent kit
US4391904A (en) 1979-12-26 1983-07-05 Syva Company Test strip kits in immunoassays and compositions therein
US4299916A (en) 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
NL8000173A (nl) 1980-01-11 1981-08-03 Akzo Nv Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
US4347312A (en) 1980-03-20 1982-08-31 Research Triangle Institute Detection of antibiotics in milk
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
US4425438A (en) 1981-03-13 1984-01-10 Bauman David S Assay method and device
US5141875A (en) 1982-01-08 1992-08-25 Environmental Diagnostics, Inc. Rotary fluid manipulator
US5073484A (en) 1982-03-09 1991-12-17 Bio-Metric Systems, Inc. Quantitative analysis apparatus and method
EP0149168B1 (de) 1983-12-19 1991-04-24 Daiichi Pure Chemicals Co. Ltd. Immuntest
US4695554A (en) 1984-02-14 1987-09-22 Becton Dickinson And Company Sac or liposome containing dye (sulforhodamine) for immunoassay
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
US4743560A (en) 1984-03-26 1988-05-10 Becton Dickinson And Company Solid phase assay
US4678559A (en) 1984-07-23 1987-07-07 Andreas Szabados Test specimen container for pasty specimen material
DE3427114A1 (de) * 1984-07-23 1986-01-30 A. Dr.med. 8022 Grünwald Szabados Probenaufnahmegefaess fuer pastoeses probenmaterial und verfahren zur verarbeitung von pastoesem probenmaterial
US4999285A (en) 1984-11-15 1991-03-12 Syntex (U.S.A.) Inc. Chromatographic cassette
DE3445816C1 (de) 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
GB8526741D0 (en) 1985-10-30 1985-12-04 Boots Celltech Diagnostics Binding assay device
US5236826A (en) 1985-12-10 1993-08-17 Murex Corporation Immunoassay for the detection or quantitation of an analyte
US5501949A (en) 1985-12-10 1996-03-26 Murex Diagnostics Corporation Particle bound binding component immunoassay
AU602694B2 (en) 1986-06-09 1990-10-25 Ortho Diagnostic Systems Inc. Improved colloidal gold membrane assay
US5514602A (en) 1986-06-09 1996-05-07 Ortho Diagnostic Systems, Inc. Method of producing a metal sol reagent containing colloidal metal particles
US4960691A (en) 1986-09-29 1990-10-02 Abbott Laboratories Chromatographic test strip for determining ligands or receptors
US5079142A (en) 1987-01-23 1992-01-07 Synbiotics Corporation Orthogonal flow immunoassays and devices
USRE38430E1 (en) 1987-03-27 2004-02-17 Becton, Dickinson And Company Solid phase chromatographic immunoassay
CA1303983C (en) 1987-03-27 1992-06-23 Robert W. Rosenstein Solid phase assay
US4857453A (en) 1987-04-07 1989-08-15 Syntex (U.S.A.) Inc. Immunoassay device
EP0560411B1 (de) 1987-04-27 2000-07-26 Unilever N.V. Spezifische Bindungstestverfahren
US5120643A (en) 1987-07-13 1992-06-09 Abbott Laboratories Process for immunochromatography with colloidal particles
EP0299359A3 (de) 1987-07-16 1990-09-26 Abbott Laboratories System zur Zuführung von Reagenzien bei Analysevorrichtungen mit fester Phase
US4956302A (en) 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
US5275785A (en) 1987-10-30 1994-01-04 Unilever Patent Holdings B.V. Test device for detecting an analyte in a liquid sample
AU619231B2 (en) 1987-12-21 1992-01-23 Abbott Laboratories Chromatographic binding assay devices and methods
US4891313A (en) 1988-01-21 1990-01-02 Boehringer Manheim Corporation Method for determination of a component of a sample
AU2684488A (en) 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5252459A (en) 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
US6352862B1 (en) 1989-02-17 2002-03-05 Unilever Patent Holdings B.V. Analytical test device for imuno assays and methods of using same
DE69013842T2 (de) 1989-04-11 1995-03-09 Ars Holding 89 N.V., Curacao Multianalysenprobenträger.
US5714465A (en) 1989-05-19 1998-02-03 Amgen Inc. Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor
US5075078A (en) 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
US5252496A (en) 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
KR910014706A (ko) 1990-01-10 1991-08-31 원본미기재 세척이 필요없는 개량된 이뮤노어세이(immunoassay)장치
US5283038A (en) * 1990-12-18 1994-02-01 Saliva Diagnostic Systems, Inc. Fluid sampling and testing device
US5998220A (en) 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
SK192592A3 (en) * 1991-06-25 1995-04-12 Saliva Diagnostic Systems Inc Sample device
WO1993020236A1 (en) 1992-04-03 1993-10-14 Applied Biosystems, Inc. Probe composition and method
FI92882C (fi) 1992-12-29 1995-01-10 Medix Biochemica Ab Oy Kertakäyttöinen testiliuska ja menetelmä sen valmistamiseksi
US5422726A (en) 1993-02-16 1995-06-06 Tyler; Jonathan M. Solid state spectrofluorimeter and method of using the same
EP0653639B1 (de) 1993-11-12 2000-03-22 Unilever Plc Analysevorrichtung und deren Anwendung
GB9419267D0 (en) 1994-09-23 1994-11-09 Unilever Plc Assay devices
GB9505425D0 (en) 1995-03-17 1995-05-03 Unilever Plc Assay devices
US6319676B1 (en) 1995-05-02 2001-11-20 Carter Wallace, Inc. Diagnostic detection device and method
US6372515B1 (en) 1996-03-11 2002-04-16 American Bio Medica Corporation Device for the testing of fluid samples and process for making the device
US5976895A (en) 1996-03-11 1999-11-02 American Biomedica Corporation Device for the collection, testing and shipment of body fluid samples
CA2249303C (en) 1996-03-20 2012-05-08 Serex, Inc. Chromatographic immunoassay device and method utilizing particle valency for quantitation
US5753517A (en) 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
US5747273A (en) 1996-05-07 1998-05-05 Diagnostic Systems Laboratories, Inc. Immunoassay of total insulin-like growth factor binding protein-1
DE19634873A1 (de) 1996-08-29 1998-03-12 Boehringer Mannheim Gmbh System zur Unterscheidung fluoreszierender Molekülgruppen durch zeitaufgelöste Fluoreszenzmessung
US5798273A (en) 1996-09-25 1998-08-25 Becton Dickinson And Company Direct read lateral flow assay for small analytes
US5710005A (en) 1996-10-29 1998-01-20 Biocode, Inc. Analyte detection with a gradient lateral flow device
GB2322192B (en) 1997-02-14 2001-01-31 Unilever Plc Assay devices
US6544797B1 (en) 1997-04-09 2003-04-08 Biosite Diagnostics, Inc. Compositions and methods for inhibiting light-induced inactivation of biological reagents
US6103536A (en) 1997-05-02 2000-08-15 Silver Lake Research Corporation Internally referenced competitive assays
DE19748331C1 (de) 1997-10-31 1999-01-28 Primed Medizintechnik Gmbh Vorrichtung zur Aufnahme und Abgabe von Speichel
JP4071330B2 (ja) 1997-11-20 2008-04-02 大日精化工業株式会社 抗ヒトメダラシンモノクローナル抗体、その製造方法及びそれを用いる免疫学的測定方法
SE9704933D0 (sv) 1997-12-30 1997-12-30 Pharmacia & Upjohn Diag Ab Metod som utnyttjar en ny kalibrator och test kit som innehåller kalibratorn
US7713703B1 (en) 2000-11-13 2010-05-11 Biosite, Inc. Methods for monitoring the status of assays and immunoassays
US6830731B1 (en) 1998-01-05 2004-12-14 Biosite, Inc. Immunoassay fluorometer
US6194222B1 (en) 1998-01-05 2001-02-27 Biosite Diagnostics, Inc. Methods for monitoring the status of assays and immunoassays
WO1999040438A1 (en) 1998-02-03 1999-08-12 Synbiotics Corporation Device and method to detect immunoprotective antibody titers
US6267722B1 (en) 1998-02-03 2001-07-31 Adeza Biomedical Corporation Point of care diagnostic systems
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
DE19844500A1 (de) 1998-09-29 2000-03-30 Roche Diagnostics Gmbh Verfahren zur photometrischen Auswertung von Testelementen
US6379620B1 (en) 1998-11-16 2002-04-30 Barry M. Tydings Assaying device and method for in field urinalysis
ATE315784T1 (de) 1999-11-12 2006-02-15 Tuan Pham Diagnostischer testkit zum sammeln und testen von flüssigproben mit durch den benutzer konfigurierbaren teststreifen und mit wecker
US6812038B1 (en) 1999-11-18 2004-11-02 Pharmacia Diagnostics Ab Assay device and use thereof
ES2334972T3 (es) 2000-02-03 2010-03-18 DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. Inmunoensayo para medulasina humana y metodo de diagnostico de la esclerosis multiple.
US7060223B2 (en) * 2000-03-31 2006-06-13 Neogen Corporation Polymeric medium for the retention of reagent species for use in a hand-held device for the relatively rapid detection of the presence of an analyte of interest in a sample
US6777198B2 (en) 2000-10-11 2004-08-17 Pharmacia Diagnostics Ab Assay method and kit therefor
US6861214B1 (en) 2000-10-23 2005-03-01 Beckman Coulter, Inc. Immobilization of biopolymers to aminated substrates by direct adsorption
US6756202B2 (en) 2001-04-30 2004-06-29 Agilent Technologies, Inc. Reading multi-featured arrays
US6770487B2 (en) 2001-05-01 2004-08-03 Ischemia Technologies, Inc. Bar code readable diagnostic strip test
EP1847321A1 (de) * 2001-09-28 2007-10-24 OraSure Technologies, Inc. Probennehmer und Testvorrichtung
US7879293B2 (en) 2001-09-28 2011-02-01 Orasure Technologies, Inc. Sample collector and test device
US8367013B2 (en) 2001-12-24 2013-02-05 Kimberly-Clark Worldwide, Inc. Reading device, method, and system for conducting lateral flow assays
US7049150B2 (en) 2001-12-28 2006-05-23 Varian, Inc. Binding assay device with non-absorbent carrier material
WO2003062824A1 (en) 2002-01-23 2003-07-31 Boditech Inc. Lateral flow quantitative assay method and strip and laser-induced fluoerescence detection device therefor
US6805838B2 (en) 2002-03-04 2004-10-19 Barry M. Tydings Assaying device and method for in field urinalysis
US7175992B2 (en) 2002-04-10 2007-02-13 Response Biomedical Corporation Sensitive immunochromatographic assay
EP1493029B1 (de) 2002-04-10 2010-03-31 Response Biomedical Corporation Sensitives immunochromatografisches assay
US7323139B2 (en) 2002-07-26 2008-01-29 Quantum Design, Inc. Accessible assay and method of use
US7256053B2 (en) 2002-10-24 2007-08-14 Nanogen, Inc. Diagnostic device for analyte detection
US7247500B2 (en) 2002-12-19 2007-07-24 Kimberly-Clark Worldwide, Inc. Reduction of the hook effect in membrane-based assay devices
US7317532B2 (en) 2003-06-04 2008-01-08 Inverness Medical Switzerland Gmbh Flow sensing for determination of assay results
US7239394B2 (en) 2003-06-04 2007-07-03 Inverness Medical Switzerland Gmbh Early determination of assay results
US7315378B2 (en) 2003-06-04 2008-01-01 Inverness Medical Switzerland Gmbh Optical arrangement for assay reading device
US7178416B2 (en) 2003-07-08 2007-02-20 Alexeter Technologies, Llc. Radio frequency identification (RFID) test information control and tracking system
ATE416384T1 (de) 2003-08-25 2008-12-15 Marc Ramael Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
US7238538B2 (en) 2003-09-19 2007-07-03 Freitag Helmut E Chromatographic assay device and methods
DE20316987U1 (de) 2003-11-05 2004-01-15 Hitzenberger, Michael H. Auswertevorrichtung für Teststreifen mit mehreren Testfeldern
DE212004000061U1 (de) * 2003-11-14 2006-09-21 Oakville Hong Kong Co., Ltd. Schnelle Probenanalyse und Speichervorrichtungen
CA2554713C (en) * 2004-01-28 2011-11-01 Bamburgh Marrsh Llc Specimen sample collection device and test system
US20050221504A1 (en) 2004-04-01 2005-10-06 Petruno Patrick T Optoelectronic rapid diagnostic test system
US20070185679A1 (en) 2004-04-01 2007-08-09 Petruno Patrick T Indicating status of a diagnostic test system
US8128871B2 (en) 2005-04-22 2012-03-06 Alverix, Inc. Lateral flow assay systems and methods
US20070143035A1 (en) 2005-12-19 2007-06-21 Petruno Patrick T Diagnostic test reader with disabling unit
US7521259B2 (en) 2004-04-01 2009-04-21 Alverix, Inc. Assay test strips with multiple labels and reading same
US7815854B2 (en) 2004-04-30 2010-10-19 Kimberly-Clark Worldwide, Inc. Electroluminescent illumination source for optical detection systems
US20060019265A1 (en) 2004-04-30 2006-01-26 Kimberly-Clark Worldwide, Inc. Transmission-based luminescent detection systems
US7796266B2 (en) 2004-04-30 2010-09-14 Kimberly-Clark Worldwide, Inc. Optical detection system using electromagnetic radiation to detect presence or quantity of analyte
US20050244953A1 (en) 2004-04-30 2005-11-03 Kimberly-Clark Worldwide, Inc. Techniques for controlling the optical properties of assay devices
US7763454B2 (en) 2004-07-09 2010-07-27 Church & Dwight Co., Inc. Electronic analyte assaying device
US7282181B2 (en) * 2004-09-16 2007-10-16 Varian Inc. Fluid collection and testing device
EP2144064A3 (de) 2004-10-04 2010-05-26 Akers Biosciences, Inc. Zusammensetzungen und Verfahren zur Modulation des Lignins einer Pflanze
US7507373B2 (en) * 2004-12-09 2009-03-24 American Bio Medica Corp. Assay device for the testing of fluid samples
GB0427568D0 (en) 2004-12-16 2005-01-19 Resolution Chemicals Ltd Particle-size reduction apparatus, and the use thereof
US7785899B2 (en) 2005-02-18 2010-08-31 Charm Sciences, Inc. Lateral flow test kit and method for detecting an analyte
US10753931B2 (en) 2005-04-22 2020-08-25 Alverix, Inc. Assay test strips with multiple labels and reading same
WO2007111847A2 (en) 2006-03-24 2007-10-04 Aokin Ag Use of additives for the reduction of non-specific binding in assays
US7879623B2 (en) * 2006-03-31 2011-02-01 Guirguis Raouf A Integrated device for analyte, testing, confirmation, and donor identity verification
WO2007119067A1 (en) 2006-04-19 2007-10-25 It-Is International Ltd Reaction monitoring
WO2007133725A1 (en) 2006-05-12 2007-11-22 University Of Miami Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
WO2008084331A2 (en) 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
WO2008015645A2 (en) 2006-08-02 2008-02-07 Koninklijke Philips Electronics N.V. A method of determining the concentration of an analyte using analyte sensor molecules coupled to a porous membrane
US7679745B2 (en) 2006-11-21 2010-03-16 Neptec Optical Solutions Time-resolved fluorescence spectrometer for multiple-species analysis
US8405827B2 (en) 2006-11-21 2013-03-26 Ricardo Claps Time-resolved spectroscopy system and methods for multiple-species analysis in fluorescence and cavity-ringdown applications
CN101021526B (zh) 2007-03-16 2012-01-25 艾博生物医药(杭州)有限公司 一种直观显示检测结果的装置和方法
CN101059404A (zh) * 2007-05-11 2007-10-24 艾博生物医药(杭州)有限公司 液体样本收集装置
WO2009038798A1 (en) 2007-09-21 2009-03-26 Charm Sciences, Inc. Assay reader insert and method of maintaining a reader
US7988918B2 (en) 2007-11-01 2011-08-02 Complete Genomics, Inc. Structures for enhanced detection of fluorescence
US8901366B2 (en) 2007-12-14 2014-12-02 Kimberly Clark Worldwide, Inc. Urine volume hydration test devices
WO2009111254A2 (en) 2008-02-29 2009-09-11 Biomedomics, Inc. A rapid and sensitive method for quantitative determination of the level of heparin-pf4 complex induced immunoglobulin antibodies
US20110124519A1 (en) 2008-03-18 2011-05-26 Frank Walter Falkenberg Method of assessing kidney function in a human subject
US8501489B2 (en) 2008-09-26 2013-08-06 University of Pittsburgh—of the Commonwealth System of Higher Education Urinary biomarkers to predict long-term dialysis
US8046175B2 (en) 2008-10-13 2011-10-25 Actherm Inc Analytical strip reading apparatus and the analyical strip used therein
EP2375241A1 (de) 2008-12-05 2011-10-12 Actherm Inc. Teststücklesegerät mit entfernbarer firmware
US20100173423A1 (en) 2009-01-06 2010-07-08 Inverness Medical Switzerland Gmbh Multiple testing apparatus and method
DE102009010563A1 (de) * 2009-02-16 2010-08-26 Matthias W. Engel Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
US20100279301A1 (en) 2009-05-04 2010-11-04 The Regents Of The University Of Michigan Methods and compositions for diagnosing bladder cancer
US20110065136A1 (en) 2009-08-07 2011-03-17 Rules-Based Medicine, Inc. Methods and Devices for Detecting Glomerulonephritis and Associated Disorders

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190259A1 (en) * 2001-10-05 2003-10-09 Alley Kenneth A. Apparatus for sampling, storing, preserving and testing a specimen
US8163253B1 (en) * 2004-08-03 2012-04-24 Hartselle R Lawrence Method for collecting, storing, transporting and assaying a specimen
US7927562B2 (en) * 2007-12-13 2011-04-19 W.H.P.M. Inc. Collection and assay device for biological fluid

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD790074S1 (en) * 2012-11-13 2017-06-20 Premier Biotech, Inc. Saliva test device
EP2920590A4 (de) * 2012-11-13 2016-07-13 Premier Biotech Inc Screeningvorrichtung zur analyse von körperflüssigkeiten
AU2013344883B2 (en) * 2012-11-13 2019-10-31 Premier Biotech, Inc. Screening device for analysis of bodily fluids
WO2014078451A1 (en) * 2012-11-13 2014-05-22 Premier Biotech, Inc. Screening device for analysis of bodily fluids
US20160066895A1 (en) * 2013-04-30 2016-03-10 Microtri Limited Bodily Fluid Specimen Collection and Assay Device
US20220023858A1 (en) * 2013-05-24 2022-01-27 Premier Biotech, Inc. Multi-stage oral-fluid testing device
US20160273059A1 (en) * 2013-10-22 2016-09-22 Ilex Medical Ltd. Kit and method for collecting body fluid for medical diagnosis
US11008631B2 (en) * 2013-10-22 2021-05-18 Ilex Medical Ltd. Kit and method for collecting body fluid for medical diagnosis
US20160243544A1 (en) * 2013-11-14 2016-08-25 Abon Biopharm (Hangzhou) Co., Ltd. A device and method for using the device
US20170143314A1 (en) * 2015-10-19 2017-05-25 Green Panther Ventures Urine Sampling Vessel
US10980520B2 (en) * 2015-10-19 2021-04-20 Green Panther, LLC Urine sampling vessel
WO2017083843A1 (en) * 2015-11-13 2017-05-18 Dnt Scientific Research, Llc Driven flow and volumetric control devices and methods
JP6192196B1 (ja) * 2016-03-15 2017-09-06 積水メディカル株式会社 検査容器及びそれを用いた検査方法
WO2017159616A1 (ja) * 2016-03-15 2017-09-21 積水メディカル株式会社 検査容器及びそれを用いた検査方法
US11255756B2 (en) * 2016-03-15 2022-02-22 Sekisui Medical Co., Ltd. Testing vessel and testing method employing same
CN109342708A (zh) * 2018-11-09 2019-02-15 广州浩强生物科技有限公司 一种唾液检测装置
US20210307729A1 (en) * 2018-11-13 2021-10-07 Procisedx Inc. Fecal sampler
US20200383664A1 (en) * 2019-02-14 2020-12-10 Marshall Venture Partners LLC Systems and methods for fluid sample collection and testing
US11730458B2 (en) * 2019-02-14 2023-08-22 Marshall Venture Partners LLC Systems and methods for fluid sample collection and testing
CN110192898A (zh) * 2019-05-31 2019-09-03 万华普曼生物工程有限公司 唾液采检装置
CN110074823A (zh) * 2019-05-31 2019-08-02 万华普曼生物工程有限公司 唾液采检装置
CN110361549A (zh) * 2019-08-16 2019-10-22 贵州大学 一种可多次检验的验孕装置
US20210308667A1 (en) * 2020-04-06 2021-10-07 Charm Sciences, Inc. Unit device, method, and assembly
WO2021263003A1 (en) * 2020-06-24 2021-12-30 President And Fellows Of Harvard College Automatic multi-step reaction device

Also Published As

Publication number Publication date
US20190083069A1 (en) 2019-03-21
US20180008240A1 (en) 2018-01-11
EP2395921B1 (de) 2014-08-20
EP2845543A1 (de) 2015-03-11
DE102009010563A1 (de) 2010-08-26
CA2752700A1 (en) 2010-08-19
WO2010091897A1 (de) 2010-08-19
ES2524479T3 (es) 2014-12-09
US10076314B2 (en) 2018-09-18
US20150173724A1 (en) 2015-06-25
US9414813B2 (en) 2016-08-16
US20130022517A1 (en) 2013-01-24
US9462998B2 (en) 2016-10-11
EP2395921A1 (de) 2011-12-21

Similar Documents

Publication Publication Date Title
US10076314B2 (en) Device for assaying analytes in bodily fluids
US20220280141A1 (en) Method and apparatus for collecting and preparing biological samples for testing
JP4253344B2 (ja) 封止可能なサンプル保存リザーバを備える流体サンプル分析装置
CA2219529C (en) Device for the collection, testing and shipment of body fluid samples
US5260031A (en) Saliva sampling device with sample adequacy indicating system
AU764945B2 (en) Multiple analyte assay device with sample integrity monitoring system
US5268148A (en) Saliva sampling device and sample adequacy system
US6406922B2 (en) Device for the testing of body fluid samples
US7347972B1 (en) Multiple analyte assay device
US7507373B2 (en) Assay device for the testing of fluid samples
US20030195435A1 (en) Method and apparatus for collecting and transporting capillary blood samples for diagnostic and research evaluation
BRPI0806549A2 (pt) Aparelho e método de extração para dispositivo de teste de fluido corporal de alta sensibilidade
US20090269247A1 (en) Fluid collection device with expresser plug holder
CN111157717A (zh) 一种检测装置
US8623291B2 (en) Multiple analyte assay device
EP1277052A1 (de) Vorrichtung zum nachweis von analyten in verbindung mit dem ph der probe
AU2003262462B2 (en) Multiple analyte assay device

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: EXPRESS DIAGNOSTICS INT'L, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ENGEL, MATTHIAS W.;WILSON, LESLIE;JOHNSON, PAUL;SIGNING DATES FROM 20140303 TO 20141114;REEL/FRAME:034220/0397